Longevity Health Holdings, Inc. (XAGE): Cost of Revenue

Annual figures by period end, from SEC filings.

$818.1K

Year ended 2025-12-31

$691.8K

Trailing 12 months to 2026-06-30

2023-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$818.1K	n/m	2026-03-31, From 2025-01-01
2024-12-31	$6.4K	n/a	2026-03-31, From 2024-01-01
2023-12-31	$0	n/a	2025-06-17, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Longevity Health Holdings, Inc. (XAGE)	2025-12-31	$818.1K	n/m
Park Ha Biological Technology Co., Ltd. (BYAH)	2025-10-31	$142.5K	-27.0%
Meiwu Technology Co Ltd (WNW)	2025-12-31	$6.37M	n/m
Stepan Co (SCL)	2025-12-31	$2.06B	+8.1%
Church & Dwight Co Inc (CHD)	2025-12-31	$3.43B	+3.4%
Ecolab Inc. (ECL)	2025-12-31	$8.93B	+0.3%
Procter & Gamble Co (PG)	2026-06-30	$43.36B	+5.3%

Compare XAGE, BYAH, WNW, SCL side by side · Screen every company in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics ↗